Trials / Completed
CompletedNCT04794478
Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) System
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 482 (actual)
- Sponsor
- DexCom, Inc. · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System
Detailed description
The objective of this study is to establish performance of the Dexcom CGM System (System) in comparison to a blood glucose comparator method.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Dexcom Continuous Glucose Monitoring System | Dexcom Continuous Glucose Monitoring System |
Timeline
- Start date
- 2021-02-19
- Primary completion
- 2021-08-09
- Completion
- 2021-10-31
- First posted
- 2021-03-12
- Last updated
- 2022-02-18
Locations
12 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04794478. Inclusion in this directory is not an endorsement.